Key results: 12 mg dose: Average weight loss of 24.2 percent of body weight 8 mg dose: Average weight loss of 22.8 percent 4 mg dose: Average weight loss of 17.0 percent Over 90 percent of participants at 8 or 12 mg lost at least 10 percent of body weight Over 75 percent at 12 mg lost at least 20 percent Crucially, the weight loss curve had not yet plateaued at 48 weeks, suggesting longer treatment may produce even greater results
Long-term hyperglycemia aggravates -synuclein aggregation and dopaminergic neuronal loss in a Parkinsons disease mouse model
Always consult a licensed healthcare provider with any medical questions or concerns
Geneva performs all necessary labs in house, but previous results help us tailor your evaluation more efficiently
Pi-Sunyer, X, Astrup, A, Fujioka, K, et al
Retatrutide dosage information comes from clinical trials, not approved prescribing instructions